This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials
Life Biosciences, a Boston-based biotechnology company founded in 2017 by Harvard Medical School professor David Sinclair, is poised to become the first to conduct human clinical trials for a therapy that targets aging by rejuvenating cells without altering their core function. The company is developing a cellular reprogramming treatment that, if successful, could address a wide…

